Canadian Competitiveness in the Health Life Sciences

Abstract

The Canadian federal government’s recently launched Biomanufacturing and Life Sciences Strategy (BLSS) arrives on the scene after several peer countries have been moving quickly, and seriously, with their own health life sciences strategies. While Canada’s plan has much in common with the main themes of these other plans, it is questionable whether the proper policy infrastructure exists here for Canada to keep up in the highly competitive global health life sciences sector. It is within this context that the present report aims to present a high-level overview of Canadian competitiveness in the health life sciences sector.